Partners Elaine Herrmann Blais and Scott Lassman and associate Alexandra Valenti hosted a webinar on the Biologics Price Competition and Innovation Act litigation, Patent Trial and Appeal Board updates, and recent regulatory and FDA biosimilars issues.
Read the recap.